BRIEF published on 06/25/2026 at 18:20, 26 days 1 hour ago Pims Technology: Towards Optimizing Cancer Treatments Oncology Personalized Medicine PIMS Technology European Presence Therapeutic Evaluation
BRIEF published on 05/07/2026 at 10:05, 2 months 14 days ago Aton Group is organizing a webinar for shareholders and investors on May 12, 2026 Shareholders Biotechnology Webinar 2025 Results Aton Group
BRIEF published on 04/28/2026 at 18:05, 2 months 23 days ago 2025 Annual Results: Aton Group Strategic Partnerships Biotechnology Business Expansion 2025 Results Aton Group
BRIEF published on 04/23/2026 at 18:05, 2 months 28 days ago B Cell Design innovates in response to the shortage of diagnostic reagents Patented Technology In Vitro Diagnostics Monoclonal Antibodies B Cell Design Aton Group
BRIEF published on 04/01/2026 at 18:05, 3 months 20 days ago Aton Group: Towards a Reduction of Clinical Failures in Pharmaceuticals Clinical Trials Pharmaceutical R&D Aton Group Predictability
BRIEF published on 03/11/2026 at 18:35, 4 months 10 days ago Inoviem Scientific Advances Drug Development with Patient-Centric Approach Personalized Medicine Pharmaceutical Innovation Inoviem Scientific Patient-centric Drug Development Preclinical Programs
PRESS RELEASE published on 03/11/2026 at 18:30, 4 months 10 days ago ATON: UPDATE ON THE ACTIVITIES OF ITS SUBSIDIARY INOVIEM SCIENTIFIC Aton Group's subsidiary, Inoviem Scientific, transforms drug development by prioritizing patient samples & AI technology, accelerating preclinical programs with high-value translational data AI Technology Drug Development Inoviem Scientific Aton Group Patient Sample
BRIEF published on 03/11/2026 at 18:20, 4 months 10 days ago Inoviem Scientific: Advances in Pharmaceutical Development Personalized Medicine Pharmaceutical Development Translational Pharmacology Inoviem Scientific Integrated Platform
BRIEF published on 02/18/2026 at 18:35, 5 months 3 days ago Hadrien Lanvin appointed Deputy Managing Director of the Aton Group Biotechnology Life Sciences Appointment Hadrien Lanvin Aton Group
BRIEF published on 02/18/2026 at 18:35, 5 months 3 days ago Hadrien Lanvin Appointed Deputy CEO of Aton Group Biotechnology Strategic Growth Deputy CEO Hadrien Lanvin Aton Group
Published on 07/21/2026 at 17:05, 2 hours 15 minutes ago Caldwell Appoints Steven Price Co-Leader of Life Sciences & Healthcare Practice
Published on 07/21/2026 at 15:00, 4 hours 20 minutes ago Four Nines Gold Begins Maiden Drill Program at Hayden Hill
Published on 07/21/2026 at 15:00, 4 hours 20 minutes ago BlackBerry SecuSUITE Secures Renewed NIAP Common Criteria Certification, Reinforcing Leadership in Sovereign Government-Grade Secure Communications
Published on 07/21/2026 at 14:55, 4 hours 25 minutes ago Vulcan Minerals Inc. - Drilling Completed at Carbonear Zinc-Lead SEDEX Project in Newfoundland
Published on 07/21/2026 at 14:30, 4 hours 50 minutes ago Sarama Completes Sale of its West Australian Gold Assets
Published on 07/21/2026 at 18:50, 30 minutes ago Soapeya, a DN Group AG Portfolio Company, Earns Top "Excellent" Rating from Dermatest and Proves Successful in Field Use in Ghana
Published on 07/21/2026 at 18:15, 1 hour 4 minutes ago EuroTeleSites Reports Strong Q2/2026 Results with Growth Across Key Financial and Operating Metrics
Published on 07/21/2026 at 17:50, 1 hour 30 minutes ago The New Measure of an EV Isn't Range, It's Peace of Mind
Published on 07/21/2026 at 17:40, 1 hour 40 minutes ago EQS-Adhoc: Airbus to present new mid-term outlook, strengthen commitment to profitable growth and shareholder returns during investor update
Published on 07/21/2026 at 17:37, 1 hour 42 minutes ago EQS-Adhoc: Branicks Group AG updates the timetable for the publication of its 2025 annual and consolidated financial statements in light of ongoing restructuring negotiations
Published on 07/20/2026 at 18:20, 1 day 1 hour ago Covivio - 2026 Half-year results: Earnings growth driven by active asset management
Published on 07/20/2026 at 18:04, 1 day 1 hour ago Reporting on share buyback transactions carried out between July 8 and July 9, 2026
